Brijjit for Wound Closure in Gender Affirming Mastectomies

Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions:
    Gender-affirming Mastectomy
  • Age: Between 18 - 99 Years
  • Gender: Male or Female
  • Other Inclusion Criteria:
    1. Participant self-identifies as Transgender or Gender Expansive
    2. Participant will undergo primary bilateral double incision mastectomy at NYULH
    3. All clinical criteria to be eligible for primary mastectomy must be met
    4. Ability to care for donor site and adhere to wound therapy (either solo or with care-giver assistance)
    5. Willingness to return for scheduled follow-up visits through 1 year post-operatively
    6. English Speaking

You may not be eligible for this study if the following are true:

    1. Individuals with previously diagnosed allergies or a history of adverse effects related to adhesives / adhesive tapes
    2. Individuals with a history of the following prescription medication use in the last year:
      • Accutane
      • Systemic glucocorticoids
      • Local glucocorticoids or immunosuppressants (i.e. topical tacrolimus, topical clindamycin etc.) at the intervention site
    3. Individuals with a history of significant scarring or adverse scarring (hypertrophic scars or keloid scars)
    4. Individuals with pre-existing scars at the GAM wound closure site
    5. Individuals with a disorder known to negatively affect wound healing (i.e. autoimmune disease, connective tissue disease)
    6. Individuals with malnutrition
    7. Individuals with a BMI >30 kg/m2
    8. Individuals with a history of radiation therapy
    9. Active smokers or smokeless nicotine use
    10. History of Previous Mastectomy
    11. Participant is actively immunosuppressed i.e. AIDS (HIV+ acceptable), or Systemic immunosuppressants
    12. Participant unable to attend post-operative follow-ups in person
    13. Participant with a considerable history of medical non-compliance
    14. Participant is pregnant at time of operation
    15. Participant will receive GAM not including double incisions (i.e. periareolar)



If you are registered as a volunteer, please log in to contact the study team/express interest in this study.

Contact the research team to learn more about this study.

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.